Literature DB >> 2283256

Tolerance of extracellular contrast agents for magnetic resonance imaging.

H J Weinmann1, W R Press, H Gries.   

Abstract

Mesh:

Substances:

Year:  1990        PMID: 2283256     DOI: 10.1097/00004424-199009001-00023

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


× No keyword cloud information.
  6 in total

1.  Pre-surgical mapping of primary motor cortex by functional MRI at 3 T: effects of intravenous administration of Gd-DTPA.

Authors:  Shinji Naganawa; Takashi Nihashi; Hiroshi Fukatsu; Takeo Ishigaki; Ikuo Aoki
Journal:  Eur Radiol       Date:  2003-11-05       Impact factor: 5.315

2.  Rational design of protein-based MRI contrast agents.

Authors:  Jenny J Yang; Jianhua Yang; Lixia Wei; Omar Zurkiya; Wei Yang; Shunyi Li; Jin Zou; Yubin Zhou; Anna L Wilkins Maniccia; Hui Mao; Fuqiang Zhao; Russell Malchow; Shumin Zhao; Julian Johnson; Xiaoping Hu; Eirik Krogstad; Zhi-Ren Liu
Journal:  J Am Chem Soc       Date:  2008-06-25       Impact factor: 15.419

3.  Designing Calcium-Binding Proteins for Molecular MR Imaging.

Authors:  Mani Salarian; Shenghui Xue; Oluwatosin Y Ibhagui; Jenny J Yang
Journal:  Methods Mol Biol       Date:  2019

4.  Multivalent, high-relaxivity MRI contrast agents using rigid cysteine-reactive gadolinium complexes.

Authors:  Praveena D Garimella; Ankona Datta; Dante W Romanini; Kenneth N Raymond; Matthew B Francis
Journal:  J Am Chem Soc       Date:  2011-08-26       Impact factor: 15.419

5.  Contrast-enhanced MRI of the central nervous system: comparison between gadodiamide injection and gadolinium-DTPA.

Authors:  P Akeson; E Jonsson; I Haugen; S Holtås
Journal:  Neuroradiology       Date:  1995-04       Impact factor: 2.804

6.  Long-term retention of gadolinium in the skin of rodents following the administration of gadolinium-based contrast agents.

Authors:  Hubertus Pietsch; Philipp Lengsfeld; Gregor Jost; Thomas Frenzel; Joachim Hütter; Martin A Sieber
Journal:  Eur Radiol       Date:  2009-01-24       Impact factor: 5.315

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.